Myocyte [Na+]i dysregulation in heart failure and diabetic cardiomyopathy

Frontiers in Physiology

Volumn 9, Issue SEP, 2018, Pages

  Despa, Sanda ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Heart failure; Na+ glucose cotransporter; Na+ Ca2+ exchanger; Na+ H+ exchanger; Na+ K+ ATPase; Type 2 diabetes

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM ION; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM GLUCOSE COTRANSPORTER; SODIUM ION; SODIUM PROTON EXCHANGE PROTEIN;

CALCIUM TRANSPORT; CARDIAC MUSCLE CELL; DIABETIC CARDIOMYOPATHY; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENZYME ACTIVITY; ENZYME MECHANISM; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE POTENTIAL; HEART VOLUME; HOMEOSTASIS; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SODIUM CURRENT; SODIUM TRANSPORT;

EID: 85055134565     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2018.01303     Document Type: Review

References (86)

1. Aker, S., Snabaitis, A. K., Konietzka, I., Van De Sand, A., Böngler, K., Avkiran, M., et al. (2004). Inhibition of the Na+/H+ exchanger attenuates the deterioration of ventricular function during pacing-induced heart failure in rabbits. Cardiovasc. Res. 63, 273-282. Doi: 10.1016/j.cardiores.2004.04.014
2. Anzawa, R., Bernard, M., Tamareille, S., Baetz, D., Confort-Gouny, S., Gascard, J. P., et al. (2006). Intracellular sodium increase and susceptibility to ischaemia in hearts from type 2 diabetic db/db mice. Diabetologia 49, 598-606. Doi: 10.1007/s00125-005-0091-5
3. Baartscheer, A., Schumacher, C. A., van Borren, M. M., Belterman, C. N., Coronel, R., and Fiolet, J. W. (2003). Increased Na+/H+-exchange activity is the cause of increased [Na+]i and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model. Cardiovasc. Res. 57, 1015-1024. Doi: 10.1016/S0008-6363(02)00809-X
4. Baartscheer, A., Schumacher, C. A., van Borren, M. M., Belterman, C. N., Coronel, R., Opthof, T., et al. (2005). Chronic inhibition of Na+/H+-exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure. Cardiovasc. Res. 65, 83-92. Doi: 10.1016/j.cardiores.2004.09.024
5. Baartscheer, A., Schumacher, C. A., Wüst, R. C., Fiolet, J. W., Stienen, G. J., Coronel, R., et al. (2017). Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits. Diabetologia 60, 568-573. Doi: 10.1007/s00125-016-4134-x
6. Babsky, A., Doliba, N., Doliba, N., Savchenko, A., Wehrli, S., and Osbakken, M. (2001). Na+ effects on mitochondrial respiration and oxidative phosphorylation in diabetic hearts. Exp. Biol. Med. 226, 543-551. Doi: 10.1177/153537020122600606
7. Banerjee, S. K., McGaffin, K. R., Pastor-Soler, N. M., and Ahmad, F. (2009). SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states. Cardiovasc. Res. 84, 111-118. Doi: 10.1093/cvr/cvp190
8. Banerjee, S. K., Wang, D. W., Alzamora, R., Huang, X. N., Pastor-Soler, N. M., Hallows, K. R., et al. (2010). SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy. J. Mol. Cell Cardiol. 49, 683-692. Doi: 10.1016/j.yjmcc.2010.06.003
9. Bers, D. M. (2001). Excitation-Contraction Coupling and Cardiac Contractile Force, 2nd Edn. Dordrecht: Kluwer Academic. Doi: 10.1007/978-94-010-0658-3
10. Bers, D. M. (2014). Cardiac sarcoplasmic reticulum calcium leak: basis and roles in cardiac dysfunction. Annu. Rev. Physiol. 76, 107-127. Doi: 10.1146/annurev-physiol-020911-153308
11. Bertero, E., and Maack, C. (2018). Calcium signaling and reactive oxygen species in mitochondria. Circ. Res. 122, 1460-1478. Doi: 10.1161/CIRCRESAHA.118.310082
12. Boguslavskyi, A., Pavlovic, D., Aughton, K., Clark, J. E., Howie, J., Fuller, W., et al. (2014). Cardiac hypertrophy in mice expressing unphosphorylatable phospholemman. Cardiovasc. Res. 104, 72-82. Doi: 10.1093/cvr/cvu182
13. Bossuyt, J., Ai, X., Moorman, R. J., Pogwizd, S. M., and Bers, D. M. (2005). Expression and phosphorylation of the Na+-pump regulatory subunit phospholemman in heart failure. Circ. Res. 97, 558-565. Doi: 10.1161/01.RES.0000181172.27931.c3
14. Boudina, S., and Abel, E. D. (2010). Diabetic cardiomyopathy, causes and effects. Rev. Endocr. Metab. Disord. 11, 31-39. Doi: 10.1007/s11154-010-9131-7
15. Boyman, L., Williams, G. S., Khananshvili, D., Sekler, I., and Lederer, W. J. (2013). NCLX: the mitochondrial sodium calcium exchanger. J. Mol. Cell Cardiol. 59, 205-213. Doi: 10.1016/j.yjmcc.2013.03.012
16. Cardona, K., Trenor, B., and Giles, W. R. (2016). Changes in intracellular Na+ following enhancement of late Na+ current in virtual human ventricular myocytes. PLoS One 11: e0167060. Doi: 10.1371/journal.pone.0167060
17. Chattou, S., Diacono, J., and Feuvray, D. (1999). Decrease in sodium-calcium exchange and calcium currents in diabetic rat ventricular myocytes. Acta Physiol. Scand. 166, 137-144. Doi: 10.1046/j.1365-201x.1999.00547.x
18. Chaudhary, A. K., Aneja, G. K., Shukla, S., and Razi, S. M. (2015). Study on diastolic dysfunction in newly diagnosed type 2 diabetes mellitus and its correlation with glycosylated haemoglobin (HbA1C). J. Clin. Diagn. Res. 9, OC20-OC22. Doi: 10.7860/JCDR/2015/13348.6376
19. Cox, D. A., and Matlib, M. A. (1993). A role for the mitochondrial Na+-Ca2+ exchanger in the regulation of oxidative phosphorylation in isolated heart mitochondria. J. Biol. Chem. 268, 938-947.
20. Darmellah, A., Baetz, D., Prunier, F., Tamareille, S., Rücker-Martin, C., and Feuvray, D. (2007). Enhanced activity of the myocardial Na+/H+ exchanger contributes to left ventricular hypertrophy in the Goto-Kakizaki rat model of type 2 diabetes: critical role of Akt. Diabetologia 50, 1335-1344. Doi: 10.1007/s00125-007-0628-x
21. Despa, S., and Bers, D. M. (2007). Functional analysis of Na/K-ATPase isoform distribution in rat ventricular myocytes. Am. J. Physiol. Cell Physiol. 293, C321-C327. Doi: 10.1152/ajpcell.00597.2006
22. Despa, S., Bossuyt, J., Han, F., Ginsburg, K. S., Jia, L. G., Kutchai, H., et al. (2005). Phospholemman-phosphorylation mediates the ß-adrenergic effects on Na/K pump function in cardiac myocytes. Circ. Res. 97, 252-259. Doi: 10.1161/01.RES.0000176532.97731.e5
23. Despa, S., Islam, M. A., Pogwizd, S. M., and Bers, D. M. (2002a). Intracellular [Na+]i and Na+-pump rate in rat and rabbit ventricular myocytes. J. Physiol. 539, 133-143. Doi: 10.1113/jphysiol.2001.012940
24. Despa, S., Islam, M. A., Weber, C. R., Pogwizd, S. M., and Bers, D. M. (2002b). Intracellular Na+ concentration is elevated in heart failure, but Na/K-pump function is unchanged. Circulation 105, 2543-2548.
25. Despa, S., Lingrel, J. B., and Bers, D. M. (2012a). Na/K-ATPase (2-subunit preferentially affects sarcoplasmic reticulum Ca release in mouse cardiac myocytes. Cardiovasc. Res. 95, 480-486.
26. Despa, S., Margulies, K. B., Chen, L., Knowlton, A. A., Havel, P. J., Taegtmeyer, H., et al. (2012b). Hyperamylinemia contributes to heart dysfunction in obesity and diabetes, a study in humans and rats. Circ. Res. 110, 598-608. Doi: 10.1161/CIRCRESAHA.111.258285
27. Donoso, P., Mill, J. G., O'Neil, S. C., and Eisner, D. A. (1992). Fluorescence measurements of cytoplasmic and mitochondrial sodium concentration in rat ventricular myocytes. J. Physiol. 448, 493-509. Doi: 10.1113/jphysiol.1992.sp019053
28. Engelhardt, S., Hein, L., Keller, U., Kldmbt, K., and Lohse, M. J. (2002). Inhibition of Na+/H+ exchange prevents hypertrophy, fibrosis, and heart failure in ß1-adrenergic receptor transgenic mice. Circ. Res. 90, 814-819. Doi: 10.1161/01.RES.0000014966.97486.C0
29. Fliegel, L. (2009). Regulation of the Na+/H+ exchanger in the healthy and diseased myocardium. Expert Opin. Ther. Targets 13, 55-68. Doi: 10.1517/14728220802600707
30. Frommeyer, G., Rajamani, S., Grundmann, F., Stypmann, J., Osada, N., Breithardt, G., et al. (2012). New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmia. J. Card. Fail. 18, 939-949. Doi: 10.1016/j.cardfail.2012.10.017
31. Gao, J., Wang, W., Cohen, I. S., and Mathias, R. T. (2005). Transmural gradients in Na/K pump activity and [Na+]i in canine ventricle. Biophys. J. 89, 1700-1709. Doi: 10.1529/biophysj.105.062406
32. Glitsch, H. G., and Tappe, A. (1993). The Na+/K+ pump of cardiac Purkinje cells is preferentially fuelled by glycolytic ATP production. Pflugers Arch. 422, 380-385. Doi: 10.1007/BF00374294
33. Gray, R. P., McIntyre, H., Sheridan, D. S., and Fry, C. H. (2001). Intracellular sodium and contractile function in hypertrophied human and guinea-pig myocardium. Pflugers Arch. 442, 117-123. Doi: 10.1007/s004240000512
34. Griffiths, E. J. (2009). Mitochondrial calcium transport in the heart: physiological and pathological roles. J. Mol. Cell Cardiol. 46, 789-803. Doi: 10.1016/j.yjmcc.2009.03.001
35. Guha, A., Harmancey, R., and Taegtmeyer, H. (2008). Nonischemic heart failure in diabetes mellitus. Curr. Opin. Cardiol. 23, 241-248. Doi: 10.1097/HCO.0b013e3282fcc2fa
36. Hansen, P. S., Clarke, R. J., Buhagiar, K. A., Hamilton, E., Garcia, A., White, C., et al. (2007). Alloxan-induced diabetes reduces sarcolemmal Na+-K+ pump function in rabbit ventricular myocytes. Am. J. Physiol. Cell Physiol. 292, C1070-C1077. Doi: 10.1152/ajpcell.00288.2006
37. Harrison, S. M., McCall, E., and Boyet, M. R. (1992). The relationship between contraction and intracellular sodium in rat and guinea-pig ventricular myocytes. J. Physiol. 449, 517-550. Doi: 10.1113/jphysiol.1992.sp019100
38. Hasenfuss, G., Schillinger, W., Lehnart, S. E., Preuss, M., Pieske, B., Maier, L. S., et al. (1999). Relationship between Na+-Ca2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation 99, 641-648. Doi: 10.1161/01.CIR.99.5.641
39. Hattori, Y., Matsuda, N., Kimura, J., Ishitani, T., Tamada, A., Gando, S., et al. (2000). Diminished function and expression of the cardiac Na+-Ca2+ exchanger in diabetic rats: implication in Ca2+ overload. J. Physiol. 527, 85-94. Doi: 10.1111/j.1469-7793.2000.00085.x
40. Hegyi, B., Bossuyt, J., Griffiths, L. G., Shimkunas, R., Coulibaly, Z., Jian, Z., et al. (2018). Complex electrophysiological remodeling in postinfarction ischemic heart failure. Proc. Natl. Acad. Sci. U.S.A. 115, E3036-E3044. Doi: 10.1073/pnas.1718211115
41. Ingelsson, E., Sundstrom, J., Arnlov, J., Zethelius, B., and Lind, L. (2005). Insulin resistance and risk of congestive heart failure. J. Am. Med. Assoc. 294, 334-341. Doi: 10.1001/jama.294.3.334
42. Kilic, A., Huang, C. X., Rajapurohitam, V., Madwed, J. B., and Karmazyn, M. (2014). Early and transient sodium-hydrogen exchanger isoform 1 inhibition attenuates subsequent cardiac hypertrophy and heart failure following coronary artery ligation. J. Pharmacol. Exp. Ther. 351, 492-499. Doi: 10.1124/jpet.114.217091
43. Kjeldsen, K., Braendgaard, H., Sidenius, P., Larsen, J. S., and Noørgaard, A. (1987). Diabetes decreases Na+-K+ pump concentration in skeletal muscles, heart ventricular muscle, and peripheral nerves of rat. Diabetes Metab. Res. Rev. 36, 842-848.
44. Kostis, J. B., and Sanders, M. (2005). The association of heart failure with insulin resistance and the development of type 2 diabetes. Am. J. Hypertens. 18, 731-737. Doi: 10.1016/j.amjhyper.2004.11.038
45. Kusumoto, K., Haist, J. V., and Karmazyn, M. (2001). Na+/H+ exchange inhibition reduces hypertrophy and heart failure after myocardial infarction in rats. Am. J. Physiol. Heart Circ. Physiol. 280, H738-H745. Doi: 10.1152/ajpheart.2001.280.2.H738
46. Lambert, R., Srodulski, S., Peng, X., Margulies, K. B., Despa, F., and Despa, S. (2015). Intracellular Na+ concentration ([Na+]i) is elevated in diabetic hearts due to enhanced Na+-glucose cotransport. J. Am. Heart Assoc. 4: e002183. Doi: 10.1161/JAHA.115.002183
47. Leineweber, K., Heusch, G., and Schulz, R. (2007). Regulation and role of the presynaptic and myocardial Na+/H+ exchanger NHE1: effects on the sympathetic nervous system in heart failure. Cardiovasc. Drug Rev. 25, 123-131. Doi: 10.1111/j.1527-3466.2007.00010.x
48. Liu, T., and O'Rourke, B. (2008). Enhancing mitochondrial Ca2+ uptake in myocytes from failing hearts restores energy supply, and demand matching. Circ. Res. 103, 279-288. Doi: 10.1161/CIRCRESAHA.108.175919
49. Liu, T., Takimoto, E., Dimaano, V. L., DeMazumder, D., Kettlewell, S., Smith, G., et al. (2014). Inhibiting mitochondrial Na+/Ca2+ exchange prevents sudden death in a Guinea pig model of heart failure. Circ. Res. 115, 44-54. Doi: 10.1161/CIRCRESAHA.115.303062
50. Louch, W. E., Hougen, K., Moørk, H. K., Swift, F., Aronsen, J. M., Sjaastad, I., et al. (2010). Sodium accumulation promotes diastolic dysfunction in end-stage heart failure following Serca2 knockout. J. Physiol. 588, 465-478. Doi: 10.1113/jphysiol.2009.183517
51. Luongo, T. S., Lambert, J. P., Gross, P., Nwokedi, M., Lombardi, A. A., Shanmughapriya, S., et al. (2017). The mitochondrial Na+/Ca2+ exchanger is essential for Ca2+ homeostasis and viability. Nature 545, 93-97. Doi: 10.1038/nature22082
52. Maack, C., Cortassa, S., Aon, M. A., Ganesan, A. N., Liu, T., and O'Rourke, B. (2006). Elevated cytosolic Na+ decreases mitochondrial Ca2+ uptake during excitation-contraction coupling and impairs energetic adaptation in cardiac myocytes. Circ. Res. 99, 172-182. Doi: 10.1161/01.RES.0000232546.92777.05
53. Maltsev, V. A., Sabbah, H. N., Higgins, R. S., Silverman, N., Lesch, M., and Undrovinas, A. I. (1998). Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes. Circulation 98, 2545-2552. Doi: 10.1161/01.CIR.98.23.2545
54. Masoudi, F. A., and Inzucchi, S. E. (2007). Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy. Am. J. Cardiol. 99, 113B-132B. Doi: 10.1016/j.amjcard.2006.11.013
55. McCormack, J. G., Halestrap, A. P., and Denton, R. M. (1990). Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol. Rev. 70, 391-425. Doi: 10.1152/physrev.1990.70.2.391
56. Mishra, S., Reznikov, V., Maltsev, V. A., Undrovinas, N. A., Sabbah, H. N., and Undrovinas, A. (2015). Contribution of sodium channel neuronal isoform Nav1.1 to late sodium current in ventricular myocytes from failing hearts. J. Physiol. 593, 1409-1427. Doi: 10.1113/jphysiol.2014.278259
57. Nishimura, M., and Naito, S. (2005). Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. Drug Metab. Pharmacokinet. 20, 452-477. Doi: 10.2133/dmpk.20.452
58. O'Rourke, B., Kass, D. A., Tomaselli, G. F., Kääb, S., Tunin, R., and Marbán, E. (1999). Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure. Circ. Res. 84, 562-570. Doi: 10.1161/01.RES.84.5.562
59. Packer, M. (2017). Activation and inhibition of sodium-hydrogen exchanger is a mechanism that links the pathophysiology and treatment of diabetes mellitus with that of heart failure. Circulation 136, 1548-1559. Doi: 10.1161/CIRCULATIONAHA.117.030418
60. Pataky, Z., Makoundou, V., Nilsson, P., Gabriel, R. S., Lalic, K., Muscelli, E., et al. (2011). Metabolic normality in overweight and obese subjects. Which parameters? Which risks? Int. J. Obes. 35, 1208-1215. Doi: 10.1038/ijo.2010.264
61. Pieske, B., Maier, L. S., Piacentino, V. I. I. I., Weisser, J., Hasenfuss, G., and Houser, S. (2002). Rate dependence of [Na+]i and contractility in nonfailing and failing human myocardium. Circulation 106, 447-453. Doi: 10.1161/01.CIR.0000023042.50192.F4
62. Pogwizd, S. M., Qi, M., Yuan, W., Samarel, A. M., and Bers, D. M. (1999). Upregulation of Na+/Ca2+ exchanger expression and function in an arrh ythmogenic rabbit model of heart failure. Circ. Res. 85, 1009-1019. Doi: 10.1161/01.RES.85.11.1009
63. Ramratnam, M., Sharma, R. K., D'Auria, S., Lee, S. J., Wang, D., Huang, X. Y., et al. (2014). Transgenic Knockdown of Cardiac Sodium/Glucose Cotransporter 1 (SGLT1) Attenuates PRKAG2 Cardiomyopathy, Whereas Transgenic Overexpression of Cardiac SGLT1 Causes Pathologic Hypertrophy and Dysfunction in Mice. J. Am. Heart Assoc. 3: e000899. Doi: 10.1161/JAHA.114.000899
64. Schillinger, W., Teucher, N., Christians, C., Kohlhaas, M., Sossalla, S., Van Nguyen, P., et al. (2006). High intracellular Na+ preserves myocardial function at low heart rates in isolated myocardium from failing hearts. Eur. J. Heart Fail. 8, 673-680. Doi: 10.1016/j.ejheart.2006.01.013
65. Schwinger, R. H., Wang, J., Frank, K., M?ller-Ehmsen, J., Brixus, K., McDonough, A. A., et al. (1999). Reduced sodium pump (1, (3 and ß1-isoform protein levels and Na+, K+-ATPase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure. Circulation 99, 2105-2112. Doi: 10.1161/01.CIR.99.16.2105
66. Semb, S. O., Lunde, P. K., Holt, E., Tonnessen, T., Christensen, G., and Sejersted, O. M. (1998). Reduced myocardial Na-K pump capacity in congestive heart failure following myocardial infarction in rats. J. Mol. Cell Cardiol. 30, 1311-1328. Doi: 10.1006/jmcc.1998.0696
67. Sossalla, S., Wagner, S., Rasenack, E. C. L., Ruff, H., Weber, S. L., Schondube, F. A., et al. (2008). Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts-Role of late sodium current and intracellular ion accumulation. J. Mol. Cell Cardiol. 45, 32-43. Doi: 10.1016/j.yjmcc.2008.03.006
68. Swift, F., Birkeland, J. A., Tovsrud, N., Enger, U. H., Aronsen, J. M., Louch, W. E., et al. (2008). Altered Na+/Ca2+-exchanger activity due to downregulation of Na+/K+-ATPase a2-isoform in heart failure. Cardiovasc. Res. 78, 71-78. Doi: 10.1093/cvr/cvn013
69. Swift, F., Tovsrud, N., Enger, U. H., Sjaastad, I., and Sejersted, O. M. (2007). The Na+/K+-ATPase (2-isoform regulates cardiac contractility in rat cardiomyocytes. Cardiovasc. Res. 75, 109-117. Doi: 10.1016/j.cardiores.2007.03.017
70. Swift, F., Tovsrud, N., Sjaastad, I., Sejersted, O. M., Niggli, E., and Egger, M. (2010). Functional coupling of (2-isoform Na+/K+-ATPase and Ca2+ extrusion through the Na+/Ca2+-exchanger in cardiomyocytes. Cell Calcium 48, 54-60. Doi: 10.1016/j.ceca.2010.06.006
71. Taegtmeyer, H., McNulty, P., and Young, M. E. (2002). Adaptation and maladaptation of the heart in diabetes: part I: general concepts. Circulation 105, 1727-1733. Doi: 10.1161/01.CIR.0000012466.50373.E8
72. Toischer, K., Hartmann, N., Wagner, S., Fischer, T. H., Herting, J., Danner, B. C., et al. (2013). Role of late sodium current as a potential arrhythmogenic mechanism in the progression of pressure-induced heart disease. J. Mol. Cell Cardiol. 61, 111-122. Doi: 10.1016/j.yjmcc.2013.03.021
73. Uthman, L., Baartscheer, A., Bleijlevens, B., Schumacher, C. A., Fiolet, J. W. T., Koeman, A., et al. (2018). Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation. Diabetologia 61, 722-726. Doi: 10.1007/s00125-017-4509-7
74. Valdivia, C. R., Chu, W. W., Pu, J., Foell, J. D., Haworth, R. A., Wolff, M. R., et al. (2005). Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J. Mol. Cell Cardiol. 38, 475-483. Doi: 10.1016/j.yjmcc.2004.12.012
75. Van Steenbergen, A., Balteau, M., Ginion, A., Ferté, L., Battault, S., Ravenstein, C. M., et al. (2017). Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart. Sci. Rep. 7: 41166. Doi: 10.1038/srep41166
76. Verdonck, F., Volders, P. G. A., Vos, M. A., and Sipido, K. R. (2003a). Intracellular Na+ and altered Na+ transport mechanisms in cardiac hyperhtrophy and failure. J. Mol. Cell Cardiol. 35, 5-25.
77. Verdonck, F., Volders, P. G., Vos, M. A., and Sipido, K. R. (2003b). Increased Na+ concentration and altered Na+/K+ pump activity in hypertrophied canine ventricular cells. Cardiovasc. Res. 57, 1035-1043.
78. Wagner, S., Ruff, H. M., Weber, S. L., Bellmann, S., Sowa, T., Schulte, T., et al. (2011). Reactive oxygen species-activated Ca/calmodulin kinase IId is required for late I(Na) augmentation leading to cellular Na and Ca overload. Circ. Res. 108, 555-565. Doi: 10.1161/CIRCRESAHA.110.221911
79. Wright, E. M., and Loo, D. D. (2011). Hirayama BA. Biology of human sodium glucose transporters. Physiol. Rev. 91, 733-794. Doi: 10.1152/physrev.00055.2009
80. Yao, A., Su, Z., Nonaka, A., Zubair, I., Lu, L., Philipson, K. D., et al. (1998a). Effects of overexpression of the Na+-Ca2+ exchanger on [Ca2+] transients in murine ventricular myocytes. Circ. Res. 82, 657-665.
81. Yao, A., Su, Z., Nonaka, A., Zubair, I., Spitzer, K. W., Bridge, J. H., et al. (1998b). Abnormal myocyte Ca2+ homeostasis in rabbits with pacing-induced heart failure. Am. J. Physiol. 275, H1441-H1448.
82. Yokoyama, H., Gunasegaram, S., Harding, S. E., and Avkiran, M. (2000). Sarcolemmal Na+/H+ exchanger activity and expression in human ventricular myocardium. J. Am. Coll. Cardiol. 36, 534-540. Doi: 10.1016/S0735-1097(00)00730-0
83. Young, L. H., Wackers, F. J., Chyun, D. A., Davey, J. A., Barrett, E. J., Taillefer, R., et al. (2009). DIAD Investigators. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 301, 1547-1555. Doi: 10.1001/jama.2009.476
84. Young, M. E., McNulty, P., and Taegtmeyer, H. (2002). Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation 105, 1861-1870. Doi: 10.1161/01.CIR.0000012467.61045.87
85. Zhou, L., Cryan, E. V., D'Andrea, M. R., Belkowski, S., Conway, B. R., and Demarest, K. T. (2003). Human cardiomyocytes express high level of Na+/glucose cotransporter 1 (SGLT1). J. Cell. Biochem. 90, 339-346. Doi: 10.1002/jcb.10631
86. Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., et al. (2015). EMPA-REG OUTCOME Investigators. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N. Engl. J. Med. 373, 2117-2128. Doi: 10.1056/NEJMoa1504720